XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications
Purpose. To evaluate gel microstent (XEN, Aquesys, Inc) for treatment of primary open angle glaucoma (POAG). Methods. In this prospective interventional study, 13 eyes with POAG underwent XEN implantation with subconjunctival mitomycin-C. Of those eyes, 3 were pseudophakic and 10 underwent simultane...
Main Authors: | Ahmed Galal, Alper Bilgic, Rasha Eltanamly, Amr Osman |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/5457246 |
Similar Items
-
XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long-Term Follow-Up
by: Katarzyna Lewczuk, et al.
Published: (2021-01-01) -
An innovation in glaucoma surgery: XEN45 gel stent implantation
by: Sadık Altan Ozal, et al. -
XEN gel stent drainage device implantation for glaucoma
by: Peng Huang, et al.
Published: (2018-05-01) -
Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
by: Huub J. Poelman, et al.
Published: (2021-03-01) -
Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma
by: Marc Schargus, et al.
Published: (2020-12-01)